Estudi de la micoflora de S'Albufera de Mallorca

Es realitza un estudi de 72 espècies de fongs trobats a S'Albufera. D'entre el material estudiat resulten 4 cites noves per al Catàleg Micològic de l'llla de Mallorca, i un total de 29 cites noves per al Catàleg Micològic de S'Albufera. Destaca, molt especialment, la referència a una nova especie per a la ciència, recentment publicada sobre material de S'Albufera recol·lectat per dos dels autors.Seventy two taxa of fungi, found at S'Albufera, have been studied. Four of them are first records for Mallorca and 29 for S'Albufera. The reference to a new species, recently published and recorded by two of the authors, is especially important

Smoking Patterns and Receipt of Cessation Services Among Pregnant Women in Argentina and Uruguay

Introduction: The 5A’s (Ask, Advise, Assess, Assist, and Arrange) strategy, a best-practice approach for cessation counseling, has been widely implemented in high-income countries for pregnant women; however, no studies have evaluated implementation in middle-income countries. The study objectives were to assess smoking patterns and receipt of 5A’s among pregnant women in Buenos Aires, Argentina and Montevideo, Uruguay. Methods: Data were collected through administered questionnaires to women at delivery hospitalizations during October 2011–May 2012. Eligible women attended one of 12 maternity hospitals or 21 associated prenatal care clinics. The questionnaire included demographic data, tobacco use/cessation behaviors, and receipt of the 5A’s. Self-reported cessation was verified with saliva cotinine. Results: Overall, of 3400 pregnant women, 32.8% smoked at the beginning of pregnancy; 11.9% quit upon learning they were pregnant or later during pregnancy, and 20.9% smoked throughout pregnancy. Smoking prevalence varied by country with 16.1% and 26.7% who smoked throughout pregnancy in Argentina and Uruguay, respectively. Among pregnant smokers in Argentina, 23.8% reported that a provider asked them about smoking at more than one prenatal care visit; 18.5% were advised to quit; 5.3% were assessed for readiness to quit, 4.7% were provided assistance, and 0.7% reported follow-up was arranged. In Uruguay, those percentages were 36.3%, 27.9%, 5.4%, 5.6%, and 0.2%, respectively. Conclusions: Approximately, one in six pregnant women smoked throughout pregnancy in Buenos Aires and one in four in Montevideo. However, a low percentage of smokers received any cessation assistance in both countries. Healthcare providers are not fully implementing the recommended 5A’s intervention to help pregnant women quit smoking.Fil: Berrueta, Amanda Mabel. Instituto de Efectividad Clínica y Sanitaria; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Morello, Paola. Instituto de Efectividad Clínica y Sanitaria; ArgentinaFil: Alemán, Alicia. Unidad de Investigación Clínica y Epidemiológica Montevideo; UruguayFil: Tong, Van T.. Centers for Disease Control and Prevention; Estados UnidosFil: Johnson, Carolyn. Tulane School of Public Health and Tropical Medicine; Estados UnidosFil: Dietz, Patricia M.. Centers for Disease Control and Prevention; Estados UnidosFil: Farr, Sherry L.. Centers for Disease Control and Prevention; Estados UnidosFil: Mazzoni, Agustina. Instituto de Efectividad Clínica y Sanitaria; ArgentinaFil: Colomar, Mercedes. Unidad de Investigación Clínica y Epidemiológica Montevideo; UruguayFil: Ciganda, Alvaro. Unidad de Investigación Clínica y Epidemiológica Montevideo; UruguayFil: Llambi, Laura. Unidad de Investigación Clínica y Epidemiológica Montevideo; UruguayFil: Becú, Ana. Instituto de Efectividad Clínica y Sanitaria; ArgentinaFil: Gibbons, Luz. Instituto de Efectividad Clínica y Sanitaria; ArgentinaFil: Smith, Ruben A.. Centers for Disease Control and Prevention; Estados UnidosFil: Buekens, Pierre. Tulane School of Public Health and Tropical Medicine; Estados UnidosFil: Belizan, Jose. Instituto de Efectividad Clínica y Sanitaria; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Althabe, Fernando. Instituto de Efectividad Clínica y Sanitaria; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentin

Provision of medical supply kits to improve quality of antenatal care in Mozambique: a stepped-wedge cluster randomised trial

Background High levels of maternal and newborn mortality and morbidity remain a daunting reality in many low-income countries. Several interventions delivered during antenatal care have been shown to improve maternal and newborn outcomes, but stockouts of medical supplies at point of care can prevent implementation of these services. We aimed to evaluate whether a supply chain strategy based on the provision of kits could improve quality of care. Methods We did a pragmatic, stepped-wedge, cluster-randomised controlled trial at ten antenatal care clinics in Mozambique. Clinics were eligible if they were not already implementing the proposed antenatal care package; they served at least 200 new pregnant women per year; they had Maternal and Child Health (MCH) nurses; and they were willing to participate. All women attending antenatal care visits at the participating clinics were included in the trial. Participating clinics were randomly assigned to shift from control to intervention on prespecified start dates. The intervention involved four components (kits with medical supplies, a cupboard to store these supplies, a tracking sheet to monitor stocks, and a one-day training session). The primary outcomes were the proportion of women screened for anaemia and proteinuria, and the proportion of women who received mebendazole in the first antenatal care visit. The intervention was delivered under routine care conditions, and analyses were done according to the intention-to-treat principle. This trial is registered with the Pan African Clinical Trial Registry, number PACTR201306000550192. Findings Between March, 2014, and January, 2016, 218 277 antenatal care visits were registered, with 68 598 first and 149 679 follow-up visits. We found significant improvements in all three primary outcomes. In first visits, 5519 (14·6%) of 37 826 women were screened for anaemia in the control period, compared with 30 057 (97·7%) of 30 772 in the intervention period (adjusted odds ratio 832·40; 99% CI 666·81–1039·11; p<0·0001); 3739 (9·9%) of 37 826 women were screened for proteinuria in the control period, compared with 29 874 (97·1%) of 30 772 in the intervention period (1875·18; 1447·56–2429·11; p<0·0001); and 17 926 (51·4%) of 34 842 received mebendazole in the control period, compared with 24 960 (88·2%) of 28 294 in the intervention period (1·88; 1·70–2·09; p<0·0001). The effect was immediate and sustained over time, with negligible heterogeneity between sites. Interpretation A supply chain strategy that resolves stockouts at point of care can result in a vast improvement in quality during antenatal care visits, when compared with the routine national process for procurement and distribution of supplies. Funding Government of Flanders and the UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction.Fil: Betrán, Ana Pilar. Organizacion Mundial de la Salud; ArgentinaFil: Bergel, Eduardo. World Health Organization; Suiza. Instituto de Efectividad Clínica y Sanitaria; ArgentinaFil: Griffin, Sally. International Centre For Reproductive Health; MozambiqueFil: Melo, Armando. Mozambique Ministry Of Health; MozambiqueFil: Nguyen, My Huong. World Health Organization; SuizaFil: Carbonell, Alicia. World Health Organization; SuizaFil: Mondlane, Santos. Consultório de Estatística E Serviço de Soluções; MozambiqueFil: Merialdi, Mario. World Health Organization; SuizaFil: Temmerman, Marleen. World Health Organization; SuizaFil: Gülmezoglu, A Metin. World Health Organization; SuizaFil: Aleman, Alicia. World Health Organization; SuizaFil: Althabe, Fernando. World Health Organization; Suiza. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Biza, Adriano. World Health Organization; SuizaFil: Crahay, Beatrice. World Health Organization; SuizaFil: Chavane, Leonardo. World Health Organization; SuizaFil: Colomar, Mercedes. World Health Organization; SuizaFil: Delvaux, Therese. World Health Organization; SuizaFil: Dique Ali, Ussumane. World Health Organization; SuizaFil: Fersurela, Lucio. World Health Organization; SuizaFil: Geelhoed, Diederike. World Health Organization; SuizaFil: Jille-Taas, Ingeborg. World Health Organization; SuizaFil: Malapende, Celsa Regina. World Health Organization; SuizaFil: Langa, Célio. World Health Organization; SuizaFil: Osman, Nafissa Bique. World Health Organization; SuizaFil: Requejo, Jennifer. World Health Organization; SuizaFil: Timbe, Geraldo. World Health Organization; Suiz

Intraguild aggressiveness between an alien and a native predatory mite

The predatory mite Amblydromalus limonicus, non-native in Europe, can be used legally in several European countries as greenhouse biocontrol agent against thrips species, although this species is also able to feed on whiteflies and gall mites. The first record of the unintended occurrence of A. limonicus in apple orchards in Europe comes from Catalonia (Spain), where A. limonicus is well established in the native predatory mite community since 2011. The dominant species in this community is Amblyseius andersoni, which has a similar life-style as A. limonicus (large, aggressive predator with broad diet range) making intraguild (IG) interactions between the two predators likely. Thus, we tested the IG aggressiveness of native and alien female predators, when provided with IG prey (larvae). Alien females of A. limonicus proved to be highly aggressive IG predators against native larvae of A. andersoni, which were attacked earlier and more frequently than alien larvae by the native predator. Nearly all attacks by the alien predator resulted in the death of native IG prey, whereas about 10% of the alien intraguild prey escaped the attacks of the native predator. Additionally, native IG prey is smaller than alien prey, which should facilitate the overwhelming by the alien predator. We argue that the strong aggressive intraguild behavior of A. limonicus is contributing to its establishment success in the native predatory mite community.info:eu-repo/semantics/acceptedVersio

La redacción de un documento de voluntades anticipadas útil

The aim of this article is helping people who decide to make a Living Will or Advance Directives. In essence, this emphasizes the need to make objective definitions of illnesses and symptoms, and to avoid subjective expressions that would be hard to translate into the assistance field. This way, words like ‘pro-portioned’ or ‘disproportionate’, ‘ordinary’ or ‘extraordinary’, shouldn’t be used due to their difference in meaning in each person. On the contrary, this advocates words that clearly express the patients’ quality of life, such as being unable to recognize their own children or having to stay in bed all day. What’s more, it highlights the importance of stating in this document the fact of keep¬ing or eliminating hydration and nutrition in situations that may create ethical conflicts.El objetivo de este artículo es ayudar a la persona que decida realizar un docu¬mento de voluntades anticipadas. En esencia, enfatiza en la necesidad de hacer definiciones objetivas de enfermedades y síntomas, y huir de expresiones subjeti¬vas que serían de difícil traducción en el ámbito asistencial. Así, no se deberían utilizar términos como proporcionado-desproporcionado, ordinario-extraordinario, que admiten en cada persona significados diferentes. Por el contrario, aboga por términos que expresen claramente la calidad de vida, como puede ser el hecho de no conocer a mis hijos o permanecer todo el día en la cama. Por otro lado, resalta la importancia de hacer constar en el documento el hecho de mantener o suprimir la hidratación y la nutrición en las situaciones que generen conflictos éticos

Cultivation of Agaricus bitorquis mushroom as an strategy for the Integrated Pest Management of the myceliophagous mite Microdispus lambi

BACKGROUND: The phorid fly Megaselia halterata Winnertz (Diptera: Phoridae) is the principal vector of Microdispus lambi (Acari: Pygmephoroidea) in Spanish Agaricus bisporus Lange (Imbach) mushroom farms. This myceliophagous mite does not appear to be a pest in Agaricus bitorquis (Quél.) Sacc mushroom crops. This study explores the role of phorid flies as vectors of Microdispus lambi in Agaricus bitorquis mushroom crops. RESULTS: The incidence of M. lambi in A. bitorquis growing substrates did not reach appreciable levels at any point during the growing cycle. The presence of phorid flies in A. bitorquis farms was normally higher than that in the case of Agaricus bisporus Lange (Imbach) species. The percentage of phorid vectors did not statistically differ between both Agaricus crops during infection periods. However, by the end of the crop, this percentage had increased only in A. bisporus crops, coinciding with a high incidence of mites in the substrate of this mushroom species; Megaselia halterata emerging from the mushroom substrate of A. bitorquis summer crops did not carry mites as they were absent from compost and casing. CONCLUSION: M. halterata is a pest in Spanish A. bitorquis mushroom crops, meanwhile M. lambi, its phorectic mite, has shown not to be a pest of this species mushroom farms during the spring–summer growing season. A. bitorquis crops could potentially be used as an IPM measure to decrease the incidence and prevent the propagation of the myceliophagous mite M. lambi in A. bisporus mushroom growing farms.info:eu-repo/semantics/acceptedVersio

Phoretic relationship between the myceliophagous mite Microdispus lambi (Acari: Microdispidae) and mushroom flies in Spanish crops

We studied the role played by the phorid Megaselia halterata (Wood) and the sciarid Lycoriella auripila (Winnertz) in the phoretic dispersion of the myceliophagous mite Microdispus lambi (Acari: Pygmephoridae). Twenty‐four crops were monitored during 18 months in commercial mushroom farms in Castilla‐La Mancha (Spain). Adults of both species were collected weekly and the mites they carried were counted and identified. Both phorids (19.6%) and sciarids (4.4%) carried the mite M. lambi. The calculated load of each was 3.4 M. lambi mites per phorid and 1.9 per sciarid. The same percentage of male and female phorid was used as vector, but the load was slightly higher for females (1.86 mites per female compared with1.48 mites per male). A mean of 7.2% of the phorids examined in winter were vectors of M. lambi, while in spring and autumn of the first year the average was more than 22%. The mean load did not vary significantly between seasons. Inside the mushroom farms, less than 10% of a small initial population of phorids carried mites (less than two mites per phorid). As the cycle progressed, more than 35% of a larger population of emerging flies did so (average 3.5 mites per phorid vector). At the end of the growth cycle, the flies may fly off to colonise nearby farms, favouring the propagation of M. lambi from infested to uninfested crops. Megaselia halterata is the principal vector of M. lambi in the mushroom farms of Castilla‐La Mancha due to their high numbers, the high percentage carrying mites and the number of M. lambi they carry.info:eu-repo/semantics/acceptedVersio

Stone fruits, pears and citrus integrated pest management interdisciplinary network with focus on the exchange of knowledge, innovation and technology transfer (RED-MIFRUT).

The creation of a stone fruit, pear and citrus integrated pest management (IPM) interdisciplinary network (entomology, and field and post-harvest pathology) to strengthen the exchange of knowledge and experiences of participating working groups is proposed; emphasizing on the development of new methodologies to improve the IPM that reduce the use of pesticides and presence of residues, and improves the ability to transfer technology to society. The specific objectives are: 1) Promote the collaboration among the multidisciplinary groups including knowledge transfer themes, integrating the social area. 2) Elaborate guidelines for the exchange of biological and experimental material for research. 3) Facilitate the implementation of research projects coordinated by the participating groups. 4) Analyze aspects related to effective technology transfer to the society, in each of the regions, and propose specific actions. 5) Build a database of the main pests and pathogens (including their vectors) of the fruits involved, and the strategies used for their control. 6) Create the conditions to convert the network in a source of information about IPM in fruits for the social agents. 7) Promote the public-private interaction to improve the adoption of the available technologies, and guide the development of new knowledge. 8) Establish contact with other existing networks with similar themes, like the European network Endure (European Network for the Durable Exploitation of Crop Protection Strategies), and with other institutions, like IOBC. In May of 2014, the first meeting of the area coordinators for each country was held in Río Negro, Argentina. A document was elaborated with the situation and the alternatives for pest control and cultivation in the respective participating countries. The results will be available in the World Wide Web and will be broadcast in the main participating centers

Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

BACKGROUND: The Millennium Declaration in 2000 brought special global attention to HIV, tuberculosis, and malaria through the formulation of Millennium Development Goal (MDG) 6. The Global Burden of Disease 2013 study provides a consistent and comprehensive approach to disease estimation for between 1990 and 2013, and an opportunity to assess whether accelerated progress has occured since the Millennium Declaration. METHODS: To estimate incidence and mortality for HIV, we used the UNAIDS Spectrum model appropriately modified based on a systematic review of available studies of mortality with and without antiretroviral therapy (ART). For concentrated epidemics, we calibrated Spectrum models to fit vital registration data corrected for misclassification of HIV deaths. In generalised epidemics, we minimised a loss function to select epidemic curves most consistent with prevalence data and demographic data for all-cause mortality. We analysed counterfactual scenarios for HIV to assess years of life saved through prevention of mother-to-child transmission (PMTCT) and ART. For tuberculosis, we analysed vital registration and verbal autopsy data to estimate mortality using cause of death ensemble modelling. We analysed data for corrected case-notifications, expert opinions on the case-detection rate, prevalence surveys, and estimated cause-specific mortality using Bayesian meta-regression to generate consistent trends in all parameters. We analysed malaria mortality and incidence using an updated cause of death database, a systematic analysis of verbal autopsy validation studies for malaria, and recent studies (2010-13) of incidence, drug resistance, and coverage of insecticide-treated bednets. FINDINGS: Globally in 2013, there were 1·8 million new HIV infections (95% uncertainty interval 1·7 million to 2·1 million), 29·2 million prevalent HIV cases (28·1 to 31·7), and 1·3 million HIV deaths (1·3 to 1·5). At the peak of the epidemic in 2005, HIV caused 1·7 million deaths (1·6 million to 1·9 million). Concentrated epidemics in Latin America and eastern Europe are substantially smaller than previously estimated. Through interventions including PMTCT and ART, 19·1 million life-years (16·6 million to 21·5 million) have been saved, 70·3% (65·4 to 76·1) in developing countries. From 2000 to 2011, the ratio of development assistance for health for HIV to years of life saved through intervention was US$4498 in developing countries. Including in HIV-positive individuals, all-form tuberculosis incidence was 7·5 million (7·4 million to 7·7 million), prevalence was 11·9 million (11·6 million to 12·2 million), and number of deaths was 1·4 million (1·3 million to 1·5 million) in 2013. In the same year and in only individuals who were HIV-negative, all-form tuberculosis incidence was 7·1 million (6·9 million to 7·3 million), prevalence was 11·2 million (10·8 million to 11·6 million), and number of deaths was 1·3 million (1·2 million to 1·4 million). Annualised rates of change (ARC) for incidence, prevalence, and death became negative after 2000. Tuberculosis in HIV-negative individuals disproportionately occurs in men and boys (versus women and girls); 64·0% of cases (63·6 to 64·3) and 64·7% of deaths (60·8 to 70·3). Globally, malaria cases and deaths grew rapidly from 1990 reaching a peak of 232 million cases (143 million to 387 million) in 2003 and 1·2 million deaths (1·1 million to 1·4 million) in 2004. Since 2004, child deaths from malaria in sub-Saharan Africa have decreased by 31·5% (15·7 to 44·1). Outside of Africa, malaria mortality has been steadily decreasing since 1990. INTERPRETATION: Our estimates of the number of people living with HIV are 18·7% smaller than UNAIDS's estimates in 2012. The number of people living with malaria is larger than estimated by WHO. The number of people living with HIV, tuberculosis, or malaria have all decreased since 2000. At the global level, upward trends for malaria and HIV deaths have been reversed and declines in tuberculosis deaths have accelerated. 101 countries (74 of which are developing) still have increasing HIV incidence. Substantial progress since the Millennium Declaration is an encouraging sign of the effect of global action. FUNDING: Bill & Melinda Gates Foundation

Do women prefer caesarean sections? A qualitative evidence synthesis of their views and experiences

Background: Caesarean sections (CS) continue to increase worldwide. Multiple and complex factors are contributing to the increase, including non-clinical factors related to individual women, families and their interactions with health providers. This global qualitative evidence synthesis explores women’s preferences for mode of birth and factors underlying preferences for CS. Methods: Systematic database searches (MEDLINE, EMBASE, CINAHL, PsycINFO) were conducted in December 2016 and updated in May 2019 and February 2021. Studies conducted across all resource settings were eligible for inclusion, except those from China and Taiwan which have been reported in a companion publication. Phenomena of interest were opinions, views and perspectives of women regarding preferences for mode of birth, attributes of CS, societal and cultural beliefs about modes of birth, and right to choose mode of birth. Thematic synthesis of data was conducted. Confidence in findings was assessed using GRADE-CERQual. Results: We included 52 studies, from 28 countries, encompassing the views and perspectives of pregnant women, non-pregnant women, women with previous CS, postpartum women, and women’s partners. Most of the studies were conducted in high-income countries and published between 2011 and 2021. Factors underlying women preferences for CS had to do mainly with strong fear of pain and injuries to the mother and child during labour or birth (High confidence), uncertainty regarding vaginal birth (High confidence), and positive views or perceived advantages of CS (High confidence). Women who preferred CS expressed resoluteness about it, but there were also many women who had a clear preference for vaginal birth and those who even developed strategies to keep their birth plans in environments that were not supportive of vaginal births (High confidence). The findings also identified that social, cultural and personal factors as well as attributes related to health systems impact on the reasons underlying women preferences for various modes of birth (High confidence). Conclusions: A wide variety of factors underlie women’s preferences for CS in the absence of medical indications. Major factors contributing to perceptions of CS as preferable include fear of pain, uncertainty with vaginal birth and positive views on CS. Interventions need to address these factors to reduce unnecessary CS